share_log

Sana Biotechnology一度涨近320%,公司糖尿病治疗技术取得重大突破

Sana Biotechnology once surged nearly 320%, achieving a significant breakthrough in diabetes treatment technology.

Breakings ·  Jan 8 22:59

Biotechnology company Sana Biotechnology skyrocketed over 230%, briefly rising nearly 320% in early trading; the company announced positive clinical results in the study of type 1 diabetes islet cell transplantation without immunosuppressants.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment